Continuity Biosciences
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $3.0Mattributed |
|---|---|
| Latest round | grant, $3.0M, 2025-01-01attributed |
| Founded | unknown |
| Headquarters | Bradenton, Florida |
| Industry | bio |
| Stage | unknown |
| Website | continuitybiosciences.com |
Continuity Biosciences develops precision-delivery platforms that route small molecules, biologics, and cell therapies to specific tissues to widen the therapeutic window. Pipeline indications include type 1 diabetes, pancreatic cancer, HIV, oral and breast cancer, and medical aesthetics. The company positions itself between medtech and biotech, pairing engineered devices with biological payloads.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-01 | grant | $3.0M | undisclosed |
Detected tech stack
Cloudflare, Google Font API, Google Hosted Libraries, Google Tag Manager, Webflow, jquery 3.5.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $3.0M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | continuitybiosciences.com, read 2026-05-02 |
| Description | self-reported | continuitybiosciences.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.